August 26th, 2016
EpiPen’s high price due to ‘broken’ health system, CEO Heather Bresch says
Heather Bresch, CEO of the Mylan pharmaceutical company, says she blames a broken healthcare system for the skyrocketing price of EpiPens. In the wake of growing backlash, the company says the company will offer coupons and financial assistance to purchase the injectors. But some lawmakers dismiss it as a PR move. NBC’s Kristen Welker reports for TODAY from Washington, D.C.